Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3

Alcon

Status and phase: Completed; Phase 4

Conditions: Cataract

Treatments: Device: ReSTOR

Study type: Interventional

Funder types: Industry

Identifiers

NCT00719732

M07-001

Details and patient eligibility

About

A prospective evaluation of the visual parameters in a series of patients bilaterally implanted with AcrySof ReSTOR +3 Intraocular Lens (IOL).

Enrollment: 218 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Diagnosed with cataracts

Exclusion criteria

• Pre-existing conditions that could skew the results or are contraindications for the ReSTOR intraocular lens;
• <1 diopter astigmatism by keratometry readings.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

218 participants in 1 patient group

ReSTOR Aspheric +3

Experimental group

Description:

Enrolled subjects receive implantation of ReSTOR +3 intraocular lenses (IOLs) for replacement of cataract in the natural lens of the eye. The patients were to be implanted bilaterally (in both eyes).

Treatment:

Device: ReSTOR